Labcorp Current Ratio 2010-2023 | LH
Current and historical current ratio for Labcorp (LH) from 2010 to 2023. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Labcorp current ratio for the three months ending December 31, 2023 was 1.17.
| Labcorp Current Ratio Historical Data |
| Date |
Current Assets |
Current Liabilities |
Current Ratio |
| 2023-12-31 |
$3.77B |
$3.23B |
1.17 |
| 2023-09-30 |
$3.95B |
$2.90B |
1.36 |
| 2023-06-30 |
$5.12B |
$2.18B |
2.35 |
| 2023-03-31 |
$4.70B |
$2.89B |
1.63 |
| 2022-12-31 |
$4.63B |
$3.08B |
1.50 |
| 2022-09-30 |
$4.37B |
$2.52B |
1.73 |
| 2022-06-30 |
$5.03B |
$2.64B |
1.90 |
| 2022-03-31 |
$5.23B |
$2.64B |
1.98 |
| 2021-12-31 |
$5.33B |
$2.78B |
1.92 |
| 2021-09-30 |
$6.02B |
$2.89B |
2.08 |
| 2021-06-30 |
$5.69B |
$2.67B |
2.14 |
| 2021-03-31 |
$5.64B |
$3.37B |
1.67 |
| 2020-12-31 |
$5.13B |
$3.08B |
1.67 |
| 2020-09-30 |
$4.09B |
$3.01B |
1.36 |
| 2020-06-30 |
$3.41B |
$3.03B |
1.13 |
| 2020-03-31 |
$2.89B |
$2.46B |
1.18 |
| 2019-12-31 |
$2.98B |
$2.66B |
1.12 |
| 2019-09-30 |
$2.99B |
$2.56B |
1.17 |
| 2019-06-30 |
$2.85B |
$2.50B |
1.14 |
| 2019-03-31 |
$2.89B |
$2.53B |
1.14 |
| 2018-12-31 |
$2.84B |
$1.88B |
1.51 |
| 2018-09-30 |
$3.27B |
$2.11B |
1.56 |
| 2018-06-30 |
$3.02B |
$2.12B |
1.42 |
| 2018-03-31 |
$2.90B |
$2.10B |
1.38 |
| 2017-12-31 |
$2.73B |
$2.19B |
1.25 |
| 2017-09-30 |
$2.90B |
$1.54B |
1.89 |
| 2017-06-30 |
$2.52B |
$1.81B |
1.39 |
| 2017-03-31 |
$2.49B |
$1.75B |
1.42 |
| 2016-12-31 |
$2.48B |
$1.83B |
1.36 |
| 2016-09-30 |
$2.66B |
$1.91B |
1.39 |
| 2016-06-30 |
$2.64B |
$1.27B |
2.08 |
| 2016-03-31 |
$2.75B |
$1.64B |
1.67 |
| 2015-12-31 |
$2.62B |
$1.70B |
1.54 |
| 2015-09-30 |
$2.71B |
$1.84B |
1.47 |
| 2015-06-30 |
$2.59B |
$1.82B |
1.42 |
| 2015-03-31 |
$2.33B |
$1.41B |
1.65 |
| 2014-12-31 |
$1.69B |
$0.98B |
1.73 |
| 2014-09-30 |
$1.69B |
$0.75B |
2.25 |
| 2014-06-30 |
$1.57B |
$0.74B |
2.11 |
| 2014-03-31 |
$1.42B |
$0.75B |
1.89 |
| 2013-12-31 |
$1.43B |
$0.74B |
1.95 |
| 2013-09-30 |
$1.21B |
$0.68B |
1.78 |
| 2013-06-30 |
$1.15B |
$0.66B |
1.75 |
| 2013-03-31 |
$1.19B |
$0.74B |
1.61 |
| 2012-12-31 |
$1.39B |
$1.03B |
1.35 |
| 2012-09-30 |
$1.46B |
$1.12B |
1.30 |
| 2012-06-30 |
$1.06B |
$0.72B |
1.48 |
| 2012-03-31 |
$1.08B |
$0.77B |
1.41 |
| 2011-12-31 |
$1.06B |
$0.73B |
1.45 |
| 2011-09-30 |
$1.07B |
$0.98B |
1.09 |
| 2011-06-30 |
$1.08B |
$1.03B |
1.06 |
| 2011-03-31 |
$1.15B |
$1.20B |
0.96 |
| 2010-12-31 |
$1.14B |
$1.12B |
1.02 |
| 2010-09-30 |
$0.95B |
$0.95B |
1.00 |
| 2010-06-30 |
$0.92B |
$0.90B |
1.02 |
| 2010-03-31 |
$0.98B |
$0.89B |
1.11 |
| 2009-12-31 |
$0.94B |
$1.02B |
0.92 |
| 2009-09-30 |
$0.98B |
$0.60B |
1.62 |
| 2009-06-30 |
$1.06B |
$0.55B |
1.91 |
| 2009-03-31 |
$1.21B |
$0.60B |
2.03 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$17.493B |
$12.162B |
|
Laboratory Corporation of America Holdings or LabCorp is a leading healthcare diagnostics company, providing comprehensive clinical laboratory services and end-to-end drug development support. The provide vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
|
